A Senate Commerce subcommittee hearing heard from witnesses who said worker shortages will ultimately be a drag on U.S. reshoring efforts. Pharmaceutical reps warned of high energy costs, which could add to import dependence.
One of India’s pharmaceutical labs has run afoul of the FDA many times this year. The U.S. is dependent on foreign labs like Aurobindo for its drug supply. Can the government help change that?
China’s Zero Covid protests should persuade Washington, businesses, and consumers that dependence on China for manufacturing American goods will dull the shine off iconic American brands. Political risks are rising.
Inflation remains due to supply chain problems. From China’s Zero Covid to European energy costs, the price of outsourcing manufacturing is getting high. Why reshoring is an inflation curb.
The multilateral trading system, birthed on October 30, 1947, was unceremoniously knifed and left for dead by President Biden’s signing of the Inflation Reduction Act.
A China Beige Book executive makes the case for reshoring in testimony to the U.S. China Economic and Security Review Commission. Meanwhile, U.S. manufacturers continue to lose local market share to imports.
Harry Moser of the Reshoring Initiative gives his assessment of America’s reshoring efforts in testimony to the U.S. China Economic and Security Review Commission.